Noscapine Inhibits Human Prostate Cancer Progression and Metastasis in a Mouse ModelBARKEN, Israel; GELLER, Jack; ROGOSNITZKY, Moshe et al.Anticancer research. 2008, Vol 28, Num 6A, pp 3701-3704, issn 0250-7005, 4 p.Article

The orexin type 1 receptor is overexpressed in advanced prostate cancer with a neuroendocrine differentiation, and mediates apoptosisALEXANDRE, David; HAUTOT, Coralie; ANOUAR, Youssef et al.European journal of cancer (1990). 2014, Vol 50, Num 12, pp 2126-2133, issn 0959-8049, 8 p.Article

Potent CYP17 inhibitors: improved syntheses, pharmacokinetics and anti-tumor activity in the LNCaP human prostate cancer modelHANDRATTA, Venkatesh D; JELOVAC, Danijela; LONG, Brian J et al.Journal of steroid biochemistry and molecular biology. 2004, Vol 92, Num 3, pp 155-165, issn 0960-0760, 11 p.Article

Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary culturesVICENTINI, Carlo; FESTUCCIA, Claudio; GRAVINA, Giovanni Luca et al.Journal of cancer research and clinical oncology. 2003, Vol 129, Num 3, pp 165-174, issn 0171-5216, 10 p.Article

Synthesis and biological evaluations of putative metabolically stable analogs of VN/124-1 (TOK-001): Head to head anti-tumor efficacy evaluation of VN/124-1 (TOK-001) and abiraterone in LAPC-4 human prostate cancer xenograft modelBRUNO, Robert D; VASAITIS, Tadas S; GEDIYA, Lalji K et al.Steroids. 2011, Vol 76, Num 12, pp 1268-1279, issn 0039-128X, 12 p.Article

Combined Treatment Targeting HIF-Iα and Stat3 is a Potent Strategy for Prostate CancerTherapyRAMASAMY REDDY, Kavitha; YONGLI GUAN; GUOTING QIN et al.The Prostate. 2011, Vol 71, Num 16, pp 1796-1809, issn 0270-4137, 14 p.Article

A comparative study of warping and rigid body registration for the prostate and pelvic MR volumesBAOWEI FEI; KEMPER, Corey; WILSON, David L et al.Computerized medical imaging and graphics. 2003, Vol 27, Num 4, pp 267-281, issn 0895-6111, 15 p.Article